Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well high-dose topotecan works as second-line
therapy in treating patients with recurrent extensive-stage small cell lung cancer.